BioSpace News Archive

Following a record sales year and the announcement of $45 million in Series C funding, Irvine-based orthodontic innovator INBRACE® announced the addition of experienced financial executive, Kevin Cousins, as the company’s new Chief Financial Officer.

Florida Spine Institute (FSI) is the leading, and one of the most trusted, medical facilities specializing in pain management, neurology, surgery, physical medicine and rehabilitation in Tampa Bay

“I wanted to create a better way to secure my amputation wrap and protect my incision,” said an inventor, from Thornville, Ohio, “so I invented the STUMP BOOT.”

Emtora Biosciences, a privately-held, clinical stage life science company developing eRapaTM for the prevention of cancer progression today announced a poster presentation at the American Society of Clinical Oncology (ASCO) and Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Symposium to be held in Orlando, FL, February 6-8

Arcutis Biotherapeutics, Inc. announced the closing of its initial public offering of 10,781,250 shares of its common stock at a price to the public of $17.00 per share, which includes 1,406,250 shares sold upon full exercise of the underwriters’ option to purchase additional shares of common stock.

Genomma Lab will report Fourth Quarter & Full Year 2019 Results on Wednesday, February 26, 2020 after the Mexican Market (BMV) close.

Cerner Corporation (Nasdaq: CERN) today announced results for the 2019 fourth quarter and full year that ended December 28, 2019.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 8% in the company’s quarterly cash dividend, beginning in the first quarter of 2020

CooperCompanies announced it will release first quarter 2020 financial results on Thursday, March 5, 2020, at 4:15 PM ET.

TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), today announced data from a non-human primate study demonstrating favorable response to reinforced biologic material used in a hernia repair compared to seven clinically used biologic and synthetic products.